Interacting Drugs |
Duloxetine CYP2D6 Substrates vs Pegylated interferon (peginterferon) alfa-2b |
Security Level |
|
Mechanism |
Peginterferon Alfa-2b may decrease the serum concentration of CYP2D6 Substrates e.g. duloxetine. |
Management |
Monitor therapy |
Duloxetine vs Peginterferon Alfa-2b
Post Review about Duloxetine vs Peginterferon Alfa-2b Click here to cancel reply.
Other Interactions of Duloxetine
Other Interactions of Pegylated interferon (peginterferon) alfa-2b
Duloxetine vs Peginterferon Alfa-2b
Interacting Drugs |
Duloxetine vs Peginterferon Alfa-2b |
Security Level |
|
Mechanism |
Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates. |
Management |
Monitor therapy |
No comments yet.
Post Review about Duloxetine vs Peginterferon Alfa-2b Click here to cancel reply.
Other Interactions of Duloxetine
Other Interactions of Peginterferon Alfa-2b
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.